ARID3B and lung carcinoma: However, the knockdown of COX-2 with two independent shRNA sequences in the HT29-ARID3B cells did not affect PD-L1 expression (Figure S6B), which is consistent with a report showing that COX-2 inhibition did not influence PD-L1 expression in lung cancer cells 64.